Drug Sensitivity and Drug Repurposing Platform for Cancer Precision Medicine

Area of Science:

• Oncology
• Pharmacology
• Genomics

Background:

• Global health challenges include optimizing drug discovery for unmet medical needs, shifting towards non-communicable diseases.
• Non-communicable diseases are the leading cause of death globally, particularly in low- and middle-income countries.
• Precision medicine programs are essential for addressing unmet medical needs through advanced drug screening platforms.

Purpose of the Study:

• To provide a perspective on recent developments in high-throughput drug sensitivity screening platforms for cancer precision medicine.
• To elaborate on the benefits and applications of high-throughput drug screening in precision medicine.
• To explore future integration possibilities of existing platforms with novel technologies like microfluidics-based single-cell drug screening.

Main Methods:

• Review of recent advancements in high-throughput drug sensitivity screening (HTDSS) technologies.
• Discussion of the integration of HTDSS platforms with drug repurposing strategies.
• Exploration of emerging technologies such as microfluidics for single-cell drug screening.

Main Results:

• High-throughput drug sensitivity screening platforms are critical for advancing cancer precision medicine.
• These platforms offer significant benefits and diverse applications in tailoring treatments to individual patients.
• Integration with microfluidics enables single-cell level drug sensitivity analysis.

Conclusions:

• Advancements in high-throughput drug screening are pivotal for optimizing cancer precision medicine.
• Future integration with single-cell technologies promises more personalized and effective therapeutic strategies.
• Addressing unmet medical needs requires continuous innovation in drug discovery and translational research.